nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—COMT—Clearance of dopamine—SLC6A3—malignant glioma	0.0564	0.163	CbGpPWpGaD
Entacapone—COMT—Biogenic Amine Synthesis—ASMT—malignant glioma	0.0381	0.11	CbGpPWpGaD
Entacapone—UGT1A9—Nicotine Metabolism—CYP2B6—malignant glioma	0.0338	0.0976	CbGpPWpGaD
Entacapone—COMT—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—malignant glioma	0.0274	0.0791	CbGpPWpGaD
Entacapone—COMT—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—malignant glioma	0.0258	0.0743	CbGpPWpGaD
Entacapone—COMT—Dopamine metabolism—SOD1—malignant glioma	0.0151	0.0437	CbGpPWpGaD
Entacapone—Paranoid reaction—Carmustine—malignant glioma	0.015	0.0242	CcSEcCtD
Entacapone—COMT—telencephalic ventricle—malignant glioma	0.0142	0.414	CbGeAlD
Entacapone—Altered state of consciousness—Temozolomide—malignant glioma	0.0133	0.0215	CcSEcCtD
Entacapone—Disorder sight—Temozolomide—malignant glioma	0.0129	0.0208	CcSEcCtD
Entacapone—UGT1A9—Irinotecan Pathway—BCHE—malignant glioma	0.0105	0.0303	CbGpPWpGaD
Entacapone—Cerebration impaired—Temozolomide—malignant glioma	0.0105	0.0169	CcSEcCtD
Entacapone—Tooth disorder—Temozolomide—malignant glioma	0.00948	0.0153	CcSEcCtD
Entacapone—Hypokinesia—Carmustine—malignant glioma	0.00942	0.0152	CcSEcCtD
Entacapone—Paranoia—Carmustine—malignant glioma	0.00933	0.0151	CcSEcCtD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00886	0.0256	CbGpPWpGaD
Entacapone—Menorrhagia—Temozolomide—malignant glioma	0.0083	0.0134	CcSEcCtD
Entacapone—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00816	0.0132	CcSEcCtD
Entacapone—Coagulopathy—Temozolomide—malignant glioma	0.0079	0.0127	CcSEcCtD
Entacapone—Memory impairment—Temozolomide—malignant glioma	0.00783	0.0126	CcSEcCtD
Entacapone—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00747	0.0121	CcSEcCtD
Entacapone—Endocrine disorder—Temozolomide—malignant glioma	0.00742	0.012	CcSEcCtD
Entacapone—Disturbance in attention—Temozolomide—malignant glioma	0.0071	0.0115	CcSEcCtD
Entacapone—Thinking abnormal—Carmustine—malignant glioma	0.00695	0.0112	CcSEcCtD
Entacapone—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00676	0.0109	CcSEcCtD
Entacapone—Herpes simplex—Temozolomide—malignant glioma	0.00667	0.0108	CcSEcCtD
Entacapone—Gait disturbance—Carmustine—malignant glioma	0.00652	0.0105	CcSEcCtD
Entacapone—Hepatic enzyme increased—Temozolomide—malignant glioma	0.0065	0.0105	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	0.00645	0.0186	CbGpPWpGaD
Entacapone—Gait disturbance—Temozolomide—malignant glioma	0.0063	0.0102	CcSEcCtD
Entacapone—Musculoskeletal pain—Temozolomide—malignant glioma	0.00622	0.01	CcSEcCtD
Entacapone—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00615	0.00993	CcSEcCtD
Entacapone—Urinary incontinence—Carmustine—malignant glioma	0.00614	0.00992	CcSEcCtD
Entacapone—Urinary incontinence—Temozolomide—malignant glioma	0.00594	0.00958	CcSEcCtD
Entacapone—UGT1A9—Irinotecan Pathway—APC—malignant glioma	0.00569	0.0164	CbGpPWpGaD
Entacapone—Mental disability—Carmustine—malignant glioma	0.00552	0.00891	CcSEcCtD
Entacapone—Phlebitis—Carmustine—malignant glioma	0.00536	0.00865	CcSEcCtD
Entacapone—Mental disability—Temozolomide—malignant glioma	0.00533	0.00861	CcSEcCtD
Entacapone—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00513	0.00828	CcSEcCtD
Entacapone—Gastroenteritis—Temozolomide—malignant glioma	0.00503	0.00813	CcSEcCtD
Entacapone—Injury—Carmustine—malignant glioma	0.00502	0.00811	CcSEcCtD
Entacapone—Vascular purpura—Temozolomide—malignant glioma	0.00499	0.00805	CcSEcCtD
Entacapone—Hepatic failure—Temozolomide—malignant glioma	0.00497	0.00802	CcSEcCtD
Entacapone—Hot flush—Temozolomide—malignant glioma	0.00477	0.0077	CcSEcCtD
Entacapone—Menopausal symptoms—Temozolomide—malignant glioma	0.00473	0.00764	CcSEcCtD
Entacapone—Purpura—Temozolomide—malignant glioma	0.00463	0.00748	CcSEcCtD
Entacapone—COMT—Phase II conjugation—GSTT1—malignant glioma	0.00462	0.0133	CbGpPWpGaD
Entacapone—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00462	0.00746	CcSEcCtD
Entacapone—Diplopia—Carmustine—malignant glioma	0.00462	0.00746	CcSEcCtD
Entacapone—Diplopia—Temozolomide—malignant glioma	0.00446	0.0072	CcSEcCtD
Entacapone—Ataxia—Carmustine—malignant glioma	0.00434	0.00701	CcSEcCtD
Entacapone—Ataxia—Temozolomide—malignant glioma	0.0042	0.00677	CcSEcCtD
Entacapone—Muscular weakness—Carmustine—malignant glioma	0.00407	0.00658	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.00405	0.0117	CbGpPWpGaD
Entacapone—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00402	0.00649	CcSEcCtD
Entacapone—Dysphagia—Carmustine—malignant glioma	0.00399	0.00644	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—FTH1—malignant glioma	0.00397	0.0115	CbGpPWpGaD
Entacapone—Muscular weakness—Temozolomide—malignant glioma	0.00394	0.00635	CcSEcCtD
Entacapone—Dysphagia—Temozolomide—malignant glioma	0.00386	0.00623	CcSEcCtD
Entacapone—COMT—Biological oxidations—CYP2B6—malignant glioma	0.00385	0.0111	CbGpPWpGaD
Entacapone—COMT—brainstem—malignant glioma	0.00383	0.112	CbGeAlD
Entacapone—COMT—Metapathway biotransformation—CYP2B6—malignant glioma	0.0038	0.011	CbGpPWpGaD
Entacapone—Sweating increased—Temozolomide—malignant glioma	0.00376	0.00607	CcSEcCtD
Entacapone—Dysuria—Temozolomide—malignant glioma	0.00361	0.00582	CcSEcCtD
Entacapone—Hyperglycaemia—Carmustine—malignant glioma	0.0036	0.00581	CcSEcCtD
Entacapone—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00358	0.00579	CcSEcCtD
Entacapone—Pneumonia—Carmustine—malignant glioma	0.00358	0.00578	CcSEcCtD
Entacapone—Pollakiuria—Temozolomide—malignant glioma	0.00356	0.00575	CcSEcCtD
Entacapone—Erectile dysfunction—Temozolomide—malignant glioma	0.00355	0.00574	CcSEcCtD
Entacapone—Depression—Carmustine—malignant glioma	0.00355	0.00573	CcSEcCtD
Entacapone—Weight increased—Temozolomide—malignant glioma	0.00351	0.00567	CcSEcCtD
Entacapone—Weight decreased—Temozolomide—malignant glioma	0.00349	0.00563	CcSEcCtD
Entacapone—Neuropathy peripheral—Carmustine—malignant glioma	0.00349	0.00563	CcSEcCtD
Entacapone—Hyperglycaemia—Temozolomide—malignant glioma	0.00348	0.00562	CcSEcCtD
Entacapone—Urinary tract infection—Carmustine—malignant glioma	0.00346	0.00558	CcSEcCtD
Entacapone—Pneumonia—Temozolomide—malignant glioma	0.00346	0.00558	CcSEcCtD
Entacapone—Depression—Temozolomide—malignant glioma	0.00343	0.00554	CcSEcCtD
Entacapone—COMT—telencephalon—malignant glioma	0.0034	0.0993	CbGeAlD
Entacapone—Neuropathy peripheral—Temozolomide—malignant glioma	0.00337	0.00544	CcSEcCtD
Entacapone—Urinary tract infection—Temozolomide—malignant glioma	0.00334	0.0054	CcSEcCtD
Entacapone—COMT—Biological oxidations—CYP2C18—malignant glioma	0.00334	0.00964	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP2C18—malignant glioma	0.00329	0.00951	CbGpPWpGaD
Entacapone—Hepatobiliary disease—Temozolomide—malignant glioma	0.00325	0.00525	CcSEcCtD
Entacapone—Sinusitis—Temozolomide—malignant glioma	0.00323	0.00521	CcSEcCtD
Entacapone—Haemoglobin—Carmustine—malignant glioma	0.00321	0.00518	CcSEcCtD
Entacapone—COMT—Phase II conjugation—GSTP1—malignant glioma	0.0032	0.00924	CbGpPWpGaD
Entacapone—Haemorrhage—Carmustine—malignant glioma	0.00319	0.00516	CcSEcCtD
Entacapone—Hallucination—Carmustine—malignant glioma	0.00318	0.00513	CcSEcCtD
Entacapone—Hypoaesthesia—Carmustine—malignant glioma	0.00318	0.00513	CcSEcCtD
Entacapone—Haemoglobin—Temozolomide—malignant glioma	0.0031	0.00501	CcSEcCtD
Entacapone—Haemorrhage—Temozolomide—malignant glioma	0.00309	0.00498	CcSEcCtD
Entacapone—Hepatitis—Temozolomide—malignant glioma	0.00309	0.00498	CcSEcCtD
Entacapone—Visual impairment—Carmustine—malignant glioma	0.00308	0.00497	CcSEcCtD
Entacapone—Hypoaesthesia—Temozolomide—malignant glioma	0.00307	0.00496	CcSEcCtD
Entacapone—Hallucination—Temozolomide—malignant glioma	0.00307	0.00496	CcSEcCtD
Entacapone—Pharyngitis—Temozolomide—malignant glioma	0.00306	0.00495	CcSEcCtD
Entacapone—Urinary tract disorder—Temozolomide—malignant glioma	0.00305	0.00492	CcSEcCtD
Entacapone—Urethral disorder—Temozolomide—malignant glioma	0.00303	0.00489	CcSEcCtD
Entacapone—Eye disorder—Carmustine—malignant glioma	0.00299	0.00482	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	0.00298	0.0086	CbGpPWpGaD
Entacapone—Visual impairment—Temozolomide—malignant glioma	0.00297	0.0048	CcSEcCtD
Entacapone—Flushing—Carmustine—malignant glioma	0.00296	0.00479	CcSEcCtD
Entacapone—Erythema multiforme—Temozolomide—malignant glioma	0.00292	0.00471	CcSEcCtD
Entacapone—Eye disorder—Temozolomide—malignant glioma	0.00288	0.00466	CcSEcCtD
Entacapone—Cardiac disorder—Temozolomide—malignant glioma	0.00286	0.00463	CcSEcCtD
Entacapone—Flushing—Temozolomide—malignant glioma	0.00286	0.00463	CcSEcCtD
Entacapone—Alopecia—Carmustine—malignant glioma	0.00282	0.00456	CcSEcCtD
Entacapone—Mental disorder—Carmustine—malignant glioma	0.0028	0.00452	CcSEcCtD
Entacapone—Malnutrition—Carmustine—malignant glioma	0.00278	0.00449	CcSEcCtD
Entacapone—UGT1A9—Phase II conjugation—GSTT1—malignant glioma	0.00277	0.00799	CbGpPWpGaD
Entacapone—Alopecia—Temozolomide—malignant glioma	0.00273	0.0044	CcSEcCtD
Entacapone—Mental disorder—Temozolomide—malignant glioma	0.0027	0.00437	CcSEcCtD
Entacapone—COMT—Biological oxidations—GSTT1—malignant glioma	0.0027	0.0078	CbGpPWpGaD
Entacapone—Back pain—Carmustine—malignant glioma	0.00269	0.00434	CcSEcCtD
Entacapone—Malnutrition—Temozolomide—malignant glioma	0.00269	0.00434	CcSEcCtD
Entacapone—COMT—medulla oblongata—malignant glioma	0.00267	0.078	CbGeAlD
Entacapone—Dysgeusia—Temozolomide—malignant glioma	0.00263	0.00425	CcSEcCtD
Entacapone—Vision blurred—Carmustine—malignant glioma	0.00262	0.00423	CcSEcCtD
Entacapone—Tremor—Carmustine—malignant glioma	0.00261	0.00421	CcSEcCtD
Entacapone—Back pain—Temozolomide—malignant glioma	0.0026	0.0042	CcSEcCtD
Entacapone—Agitation—Carmustine—malignant glioma	0.00256	0.00413	CcSEcCtD
Entacapone—Vision blurred—Temozolomide—malignant glioma	0.00253	0.00409	CcSEcCtD
Entacapone—COMT—Biological oxidations—PTGS1—malignant glioma	0.00253	0.00731	CbGpPWpGaD
Entacapone—Tremor—Temozolomide—malignant glioma	0.00252	0.00407	CcSEcCtD
Entacapone—Ill-defined disorder—Temozolomide—malignant glioma	0.00249	0.00403	CcSEcCtD
Entacapone—Leukopenia—Carmustine—malignant glioma	0.00249	0.00402	CcSEcCtD
Entacapone—Agitation—Temozolomide—malignant glioma	0.00247	0.00399	CcSEcCtD
Entacapone—Angioedema—Temozolomide—malignant glioma	0.00246	0.00396	CcSEcCtD
Entacapone—COMT—midbrain—malignant glioma	0.00244	0.0713	CbGeAlD
Entacapone—Malaise—Temozolomide—malignant glioma	0.00242	0.00391	CcSEcCtD
Entacapone—Vertigo—Temozolomide—malignant glioma	0.00241	0.0039	CcSEcCtD
Entacapone—Convulsion—Carmustine—malignant glioma	0.00241	0.00389	CcSEcCtD
Entacapone—Leukopenia—Temozolomide—malignant glioma	0.00241	0.00388	CcSEcCtD
Entacapone—Hypertension—Carmustine—malignant glioma	0.0024	0.00388	CcSEcCtD
Entacapone—COMT—spinal cord—malignant glioma	0.00238	0.0696	CbGeAlD
Entacapone—Palpitations—Temozolomide—malignant glioma	0.00237	0.00383	CcSEcCtD
Entacapone—Chest pain—Carmustine—malignant glioma	0.00237	0.00382	CcSEcCtD
Entacapone—Myalgia—Carmustine—malignant glioma	0.00237	0.00382	CcSEcCtD
Entacapone—Anxiety—Carmustine—malignant glioma	0.00236	0.00381	CcSEcCtD
Entacapone—Cough—Temozolomide—malignant glioma	0.00234	0.00379	CcSEcCtD
Entacapone—Convulsion—Temozolomide—malignant glioma	0.00233	0.00376	CcSEcCtD
Entacapone—Hypertension—Temozolomide—malignant glioma	0.00232	0.00375	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—CYP2B6—malignant glioma	0.00231	0.00666	CbGpPWpGaD
Entacapone—Confusional state—Carmustine—malignant glioma	0.00229	0.00369	CcSEcCtD
Entacapone—Myalgia—Temozolomide—malignant glioma	0.00229	0.00369	CcSEcCtD
Entacapone—Anxiety—Temozolomide—malignant glioma	0.00228	0.00368	CcSEcCtD
Entacapone—UGT1A9—Metapathway biotransformation—CYP2B6—malignant glioma	0.00228	0.00657	CbGpPWpGaD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00227	0.00367	CcSEcCtD
Entacapone—Oedema—Carmustine—malignant glioma	0.00227	0.00366	CcSEcCtD
Entacapone—Discomfort—Temozolomide—malignant glioma	0.00226	0.00365	CcSEcCtD
Entacapone—Dry mouth—Temozolomide—malignant glioma	0.00224	0.00361	CcSEcCtD
Entacapone—Thrombocytopenia—Carmustine—malignant glioma	0.00222	0.00359	CcSEcCtD
Entacapone—Confusional state—Temozolomide—malignant glioma	0.00221	0.00357	CcSEcCtD
Entacapone—Oedema—Temozolomide—malignant glioma	0.00219	0.00354	CcSEcCtD
Entacapone—Anorexia—Carmustine—malignant glioma	0.00216	0.00349	CcSEcCtD
Entacapone—Nervous system disorder—Temozolomide—malignant glioma	0.00215	0.00347	CcSEcCtD
Entacapone—Thrombocytopenia—Temozolomide—malignant glioma	0.00215	0.00347	CcSEcCtD
Entacapone—Skin disorder—Temozolomide—malignant glioma	0.00213	0.00344	CcSEcCtD
Entacapone—Hypotension—Carmustine—malignant glioma	0.00212	0.00342	CcSEcCtD
Entacapone—Hyperhidrosis—Temozolomide—malignant glioma	0.00212	0.00342	CcSEcCtD
Entacapone—Anorexia—Temozolomide—malignant glioma	0.00209	0.00338	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—BCHE—malignant glioma	0.00209	0.00602	CbGpPWpGaD
Entacapone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00207	0.00334	CcSEcCtD
Entacapone—Insomnia—Carmustine—malignant glioma	0.00205	0.00331	CcSEcCtD
Entacapone—Paraesthesia—Carmustine—malignant glioma	0.00204	0.00329	CcSEcCtD
Entacapone—Dyspnoea—Carmustine—malignant glioma	0.00202	0.00327	CcSEcCtD
Entacapone—Somnolence—Carmustine—malignant glioma	0.00202	0.00326	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—CYP2C18—malignant glioma	0.002	0.00578	CbGpPWpGaD
Entacapone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.002	0.00323	CcSEcCtD
Entacapone—Insomnia—Temozolomide—malignant glioma	0.00198	0.0032	CcSEcCtD
Entacapone—UGT1A9—Metapathway biotransformation—CYP2C18—malignant glioma	0.00197	0.0057	CbGpPWpGaD
Entacapone—Decreased appetite—Carmustine—malignant glioma	0.00197	0.00319	CcSEcCtD
Entacapone—Paraesthesia—Temozolomide—malignant glioma	0.00197	0.00318	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.00196	0.00566	CbGpPWpGaD
Entacapone—Gastrointestinal disorder—Carmustine—malignant glioma	0.00196	0.00316	CcSEcCtD
Entacapone—Dyspnoea—Temozolomide—malignant glioma	0.00196	0.00316	CcSEcCtD
Entacapone—Somnolence—Temozolomide—malignant glioma	0.00195	0.00315	CcSEcCtD
Entacapone—Pain—Carmustine—malignant glioma	0.00194	0.00313	CcSEcCtD
Entacapone—Constipation—Carmustine—malignant glioma	0.00194	0.00313	CcSEcCtD
Entacapone—COMT—central nervous system—malignant glioma	0.00193	0.0564	CbGeAlD
Entacapone—Dyspepsia—Temozolomide—malignant glioma	0.00193	0.00312	CcSEcCtD
Entacapone—UGT1A9—Phase II conjugation—GSTP1—malignant glioma	0.00192	0.00553	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—MYC—malignant glioma	0.00191	0.00551	CbGpPWpGaD
Entacapone—Decreased appetite—Temozolomide—malignant glioma	0.00191	0.00308	CcSEcCtD
Entacapone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00189	0.00306	CcSEcCtD
Entacapone—COMT—Metabolism—RTEL1—malignant glioma	0.00189	0.00547	CbGpPWpGaD
Entacapone—Fatigue—Temozolomide—malignant glioma	0.00189	0.00305	CcSEcCtD
Entacapone—COMT—cerebellum—malignant glioma	0.00189	0.0552	CbGeAlD
Entacapone—Pain—Temozolomide—malignant glioma	0.00188	0.00303	CcSEcCtD
Entacapone—Constipation—Temozolomide—malignant glioma	0.00188	0.00303	CcSEcCtD
Entacapone—COMT—Biological oxidations—GSTP1—malignant glioma	0.00187	0.00541	CbGpPWpGaD
Entacapone—Feeling abnormal—Carmustine—malignant glioma	0.00187	0.00302	CcSEcCtD
Entacapone—Gastrointestinal pain—Carmustine—malignant glioma	0.00186	0.003	CcSEcCtD
Entacapone—COMT—Metapathway biotransformation—GSTP1—malignant glioma	0.00185	0.00533	CbGpPWpGaD
Entacapone—Feeling abnormal—Temozolomide—malignant glioma	0.00181	0.00292	CcSEcCtD
Entacapone—Abdominal pain—Carmustine—malignant glioma	0.00179	0.0029	CcSEcCtD
Entacapone—Body temperature increased—Carmustine—malignant glioma	0.00179	0.0029	CcSEcCtD
Entacapone—Gastrointestinal pain—Temozolomide—malignant glioma	0.00179	0.0029	CcSEcCtD
Entacapone—Urticaria—Temozolomide—malignant glioma	0.00174	0.00281	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.00174	0.00503	CbGpPWpGaD
Entacapone—Abdominal pain—Temozolomide—malignant glioma	0.00173	0.0028	CcSEcCtD
Entacapone—Body temperature increased—Temozolomide—malignant glioma	0.00173	0.0028	CcSEcCtD
Entacapone—Hypersensitivity—Carmustine—malignant glioma	0.00167	0.0027	CcSEcCtD
Entacapone—Asthenia—Carmustine—malignant glioma	0.00163	0.00263	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—GSTT1—malignant glioma	0.00162	0.00467	CbGpPWpGaD
Entacapone—Hypersensitivity—Temozolomide—malignant glioma	0.00162	0.00261	CcSEcCtD
Entacapone—COMT—Neuronal System—BCHE—malignant glioma	0.0016	0.00461	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC5A5—malignant glioma	0.00159	0.00458	CbGpPWpGaD
Entacapone—Asthenia—Temozolomide—malignant glioma	0.00157	0.00254	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.00155	0.00448	CbGpPWpGaD
Entacapone—Diarrhoea—Carmustine—malignant glioma	0.00155	0.00251	CcSEcCtD
Entacapone—Pruritus—Temozolomide—malignant glioma	0.00155	0.00251	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.00155	0.00447	CbGpPWpGaD
Entacapone—COMT—brain—malignant glioma	0.00153	0.0448	CbGeAlD
Entacapone—UGT1A9—Biological oxidations—PTGS1—malignant glioma	0.00152	0.00438	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC6A3—malignant glioma	0.00151	0.00436	CbGpPWpGaD
Entacapone—COMT—Neuronal System—SLC6A3—malignant glioma	0.0015	0.00434	CbGpPWpGaD
Entacapone—Dizziness—Carmustine—malignant glioma	0.0015	0.00242	CcSEcCtD
Entacapone—Diarrhoea—Temozolomide—malignant glioma	0.0015	0.00242	CcSEcCtD
Entacapone—UGT1A9—PPARA activates gene expression—NCOR1—malignant glioma	0.00147	0.00425	CbGpPWpGaD
Entacapone—Dizziness—Temozolomide—malignant glioma	0.00145	0.00234	CcSEcCtD
Entacapone—Vomiting—Carmustine—malignant glioma	0.00144	0.00233	CcSEcCtD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—malignant glioma	0.00144	0.00416	CbGpPWpGaD
Entacapone—Rash—Carmustine—malignant glioma	0.00143	0.00231	CcSEcCtD
Entacapone—Dermatitis—Carmustine—malignant glioma	0.00143	0.00231	CcSEcCtD
Entacapone—Headache—Carmustine—malignant glioma	0.00142	0.0023	CcSEcCtD
Entacapone—Vomiting—Temozolomide—malignant glioma	0.00139	0.00225	CcSEcCtD
Entacapone—Rash—Temozolomide—malignant glioma	0.00138	0.00223	CcSEcCtD
Entacapone—Dermatitis—Temozolomide—malignant glioma	0.00138	0.00223	CcSEcCtD
Entacapone—Headache—Temozolomide—malignant glioma	0.00137	0.00222	CcSEcCtD
Entacapone—Nausea—Carmustine—malignant glioma	0.00135	0.00218	CcSEcCtD
Entacapone—Nausea—Temozolomide—malignant glioma	0.0013	0.0021	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—GSTP1—malignant glioma	0.00128	0.00369	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.00118	0.00342	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—RTEL1—malignant glioma	0.00113	0.00327	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.00113	0.00325	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTP1—malignant glioma	0.00112	0.00324	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTP1—malignant glioma	0.00111	0.00319	CbGpPWpGaD
Entacapone—COMT—Metabolism—COX8A—malignant glioma	0.00109	0.00314	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—BRAF—malignant glioma	0.00106	0.00307	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—PPARG—malignant glioma	0.00106	0.00305	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—malignant glioma	0.00103	0.00298	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—PDGFB—malignant glioma	0.00101	0.00292	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—malignant glioma	0.000994	0.00287	CbGpPWpGaD
Entacapone—COMT—Metabolism—ASMT—malignant glioma	0.000925	0.00267	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000892	0.00257	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000889	0.00257	CbGpPWpGaD
Entacapone—COMT—Metabolism—BCAN—malignant glioma	0.000869	0.00251	CbGpPWpGaD
Entacapone—COMT—Neuronal System—BRAF—malignant glioma	0.000816	0.00235	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000811	0.00234	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000784	0.00226	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—malignant glioma	0.000712	0.00206	CbGpPWpGaD
Entacapone—COMT—Metabolism—IDH2—malignant glioma	0.000701	0.00202	CbGpPWpGaD
Entacapone—COMT—Neuronal System—MDM2—malignant glioma	0.000683	0.00197	CbGpPWpGaD
Entacapone—COMT—Neuronal System—RAF1—malignant glioma	0.000681	0.00197	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP2B6—malignant glioma	0.000659	0.0019	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—COX8A—malignant glioma	0.000651	0.00188	CbGpPWpGaD
Entacapone—COMT—Metabolism—IDH1—malignant glioma	0.000603	0.00174	CbGpPWpGaD
Entacapone—COMT—Metabolism—SPHK1—malignant glioma	0.000583	0.00168	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000582	0.00168	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP2C18—malignant glioma	0.000571	0.00165	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ASMT—malignant glioma	0.000554	0.0016	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000541	0.00156	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—BCAN—malignant glioma	0.000521	0.0015	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTT1—malignant glioma	0.000462	0.00133	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS1—malignant glioma	0.000433	0.00125	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—IDH2—malignant glioma	0.00042	0.00121	CbGpPWpGaD
Entacapone—COMT—Metabolism—BCHE—malignant glioma	0.000402	0.00116	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC5A5—malignant glioma	0.000398	0.00115	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000396	0.00114	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP2B6—malignant glioma	0.000395	0.00114	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—IDH1—malignant glioma	0.000361	0.00104	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SPHK1—malignant glioma	0.000349	0.00101	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP2C18—malignant glioma	0.000342	0.000988	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000323	0.000931	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTP1—malignant glioma	0.00032	0.000924	CbGpPWpGaD
Entacapone—COMT—Metabolism—CAT—malignant glioma	0.000312	0.000899	CbGpPWpGaD
Entacapone—COMT—Metabolism—NCOR1—malignant glioma	0.000294	0.000849	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000294	0.000848	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000284	0.000819	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTT1—malignant glioma	0.000277	0.000799	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS1—malignant glioma	0.000259	0.000749	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000258	0.000746	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—BCHE—malignant glioma	0.000241	0.000696	CbGpPWpGaD
Entacapone—COMT—Metabolism—CAV1—malignant glioma	0.00024	0.000692	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC5A5—malignant glioma	0.000238	0.000687	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000225	0.00065	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000223	0.000644	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CG—malignant glioma	0.000219	0.000631	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPARG—malignant glioma	0.000211	0.000609	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000195	0.000562	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CD—malignant glioma	0.000192	0.000554	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTP1—malignant glioma	0.000192	0.000554	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CAT—malignant glioma	0.000187	0.000539	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NCOR1—malignant glioma	0.000176	0.000509	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CB—malignant glioma	0.000167	0.000483	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS2—malignant glioma	0.000166	0.000479	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTEN—malignant glioma	0.000145	0.000418	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CAV1—malignant glioma	0.000144	0.000415	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000137	0.000396	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CG—malignant glioma	0.000131	0.000378	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPARG—malignant glioma	0.000126	0.000365	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CD—malignant glioma	0.000115	0.000332	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CA—malignant glioma	0.000102	0.000295	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CB—malignant glioma	0.0001	0.00029	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS2—malignant glioma	9.94e-05	0.000287	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTEN—malignant glioma	8.67e-05	0.00025	CbGpPWpGaD
Entacapone—COMT—Metabolism—AKT1—malignant glioma	8.34e-05	0.000241	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CA—malignant glioma	6.11e-05	0.000176	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AKT1—malignant glioma	4.99e-05	0.000144	CbGpPWpGaD
